Low fasting glucose‐to‐estimated average glucose ratio was associated with superior response to insulin degludec/aspart compared with basal insulin in patients with type 2 diabetes

AIMS/INTRODUCTION: The benefits of once‐daily insulin degludec/aspart (IDegAsp) compared with basal insulin in type 2 diabetes patients have not been established. MATERIALS AND METHODS: This was a retrospective observational study. From a basal insulin cohort from three referral hospitals, patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Han Na, Yang, Ye Seul, Oh, Tae Jung, Koo, Bo Kyung, Lee, Seong Ok, Park, Kyong Soo, Jang, Hak Chul, Jung, Hye Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756314/
https://www.ncbi.nlm.nih.gov/pubmed/34291584
http://dx.doi.org/10.1111/jdi.13634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756314/
https://www.ncbi.nlm.nih.gov/pubmed/34291584
http://dx.doi.org/10.1111/jdi.13634

Ejemplares similares